TGR was also identified as a multifunctional oxidoreductase with a remarkably wide substrate specificity, capable of directly reducing peroxides, selenium-containing compounds, and several important low-molecular-weight antioxidants, as well as Trx, DTNB, GSSG, and GSH-HED
Progress stalls
A placebo-controlled cardiovascular outcomes trial of tirzepatide in people with obesity at high cardiovascular risk but without type 2 diabetes, SURMOUNT-MMO, is underway
BBB disruption in healthy aging The BBB undergoes a number of deleterious changes during normal aging
Products like Biotene mouthwash, CloSYS, or any formulation labeled "alcohol-free" are appropriate substitutes

Semaglutide | Feature | Tirzepatide | Semaglutide | Mechanism | Dual GIP/GLP-1 agonist | GLP-1 agonist only | | Average weight loss | 20-25% | 15-17% | | Dosing frequency | Weekly | Weekly | | Side effects | Generally comparable | GI side effects common | | Cost (brand) | $1,000-1,200/month | $1,000-1,400/month | More detail on the science behind GIP and GLP-1 Explanation of how these hormones naturally work in the body Why dual-action is more effective Comparison with older weight loss medications SURMOUNT Clinical Trial Program SURMOUNT-1 Trial (published in NEJM 2022): 2,539 participants without diabetes 72-week study Results by dose: * 5 mg: 15.0% weight loss * 10 mg: 19.5% weight loss * 15 mg: 20.9% weight loss * Placebo: 3.1% weight loss 89% of participants on 15 mg dose lost at least 5% body weight 57% lost at least 20% body weight on highest dose SURMOUNT-2 Trial: Participants with type 2 diabetes Average weight loss 12-15% (diabetes makes weight loss harder) Significant improvements in HbA1c and cardiovascular risk factors SURMOUNT-3 Trial: Weight maintenance after initial loss Participants who continued tirzepatide maintained weight loss Those who switched to placebo regained significant weight Additional Benefits Observed: Reduced waist circumference Improved blood pressure Better cholesterol levels Decreased liver fat Improved quality of life scores Expand by adding: More details on study design and methodology Specific patient examples from trials Comparison with other weight loss interventions (surgery, other medications) Long-term follow-up data Who Is a Candidate for Tirzepatide
